AVIEW RT ACS

by Coreline Soft  · Based in South Korea → — Fully automatic organ segmentation based on artificial intelligence. Auto Contouring Server for Radiotherapy.
Oncology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

AVIEW RT ACS by Coreline Soft is an advanced AI-based radiotherapy autocontouring system designed to enhance the efficiency and accuracy of radiation treatment planning. Utilizing deep learning technology, it automatically segments organs at risk (OARs) on CT images, significantly reducing the time and effort required for manual contouring. The system supports contouring for various anatomical regions, including the head and neck, breast, abdomen, and pelvis. By generating output in RT-DICOM format, AVIEW RT ACS seamlessly integrates into existing radiation treatment planning workflows, aiming to improve consistency and reduce variability among medical professionals. It is part of Coreline Soft’s broader AVIEW platform, which focuses on AI-driven diagnostic solutions for medical imaging.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Deep learning-based automatic organ segmentation
  • Supports head & neck, breast, abdomen, and pelvis contouring
  • Generates RT-DICOM format output
  • Reduces manual contouring time
  • Increases accuracy and consistency in contouring
  • Integrates with existing radiation treatment planning workflows (DICOM 3.0 support)
  • AI-powered medical image analysis
  • Automated contouring server for radiotherapy

Use Cases

  • Radiation treatment planning
  • Automated segmentation of organs at risk (OARs)
  • Breast radiotherapy planning
  • Head and neck radiotherapy planning
  • Abdomen and pelvis radiotherapy planning
  • Streamlining radiology workflows

What Physicians Need to Know

Key Capabilities
AVIEW RT ACS is an AI-based, fully automated contouring solution that supports radiation therapy planning. It automatically segments normal organs and target structures on CT scans. The system generates head and neck, breast, abdomen, and pelvis contouring in an RT-DICOM format. It also provides segmentation results for on-screen review and can be used for research environments.
Clinical Utility
AVIEW RT ACS aims to reduce the time spent on segmenting normal organs, which can be a fatiguing task, allowing clinicians to focus more on treatment planning. It provides AI-based analysis information that can be referenced during the reading process, helping clinicians review a broader range of findings and identify cases requiring priority review as examination volumes increase.
Integration Options
The data from CT scans for radiation treatment planning can be transferred to AVIEW RT ACS, which then automatically segments normal organs upon data upload. Coreline Soft is also advancing PACS-integrated, "zero-click" automation in collaboration with INFINITT North America (INA).
Compliance Status
AVIEW RT ACS has received FDA 510(k) clearance in the U.S. It also has CE Mark approval.
Pricing Model
unknown
User Experience
The AI design is built around clinical workflows, aiming to provide AI-based analysis information that can be referenced during the reading process.
Support Quality
Coreline Soft offers contact through email for inquiries.
Implementation Complexity
Coreline Soft states they will guide users based on their organ segmentation workflow and use environment.
Evidence Base
The AVIEW platform's analytical performance and potential clinical use are explored through research publications in peer-reviewed journals. Coreline Soft has processed 2.5 million AI analysis cases across 19 countries and has over 100 related studies and publications.
Physician Tip

AVIEW RT ACS can significantly reduce the manual effort and time involved in organ segmentation for radiation therapy planning, allowing for more focus on critical treatment strategy. The FDA and CE clearances indicate a level of regulatory confidence in the tool. Consider how its automated contouring for various body regions (head and neck, breast, abdomen, pelvis) could streamline your specific workflow. The integration with PACS and "zero-click" automation could further enhance efficiency. The availability of research publications suggests a commitment to validating the software's performance.

AVIEW RT ACS is designed to integrate with radiation treatment planning workflows by accepting data from CT scans and automatically segmenting organs upon upload. Coreline Soft is actively working on deeper integration with clinical workflows and healthcare platforms, including PACS-integrated, "zero-click" automation in collaboration with INFINITT North America.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentOn-premises (PACS integration)
Data ExportUnknown
TrainingUnknown
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Radiology

Support & Reliability

Training ProvidedUnknown

What the Web Says

AVIEW RT ACS by Coreline Soft is an AI-powered auto-contouring solution designed for radiation therapy planning. It automatically segments organs from CT scans, aiming to reduce the time and effort clinicians spend on manual contouring, thereby allowing them to focus more on treatment planning. The system has received FDA clearance and supports various anatomical sites including head and neck, breast, abdomen, and pelvis.

Overall: Positive

Strengths

  • Automated organ segmentation using deep learning AI technology.
  • High accuracy in automatic segmentation performance for various organs.
  • Reduces time and effort spent on manual contouring for radiation therapy planning.
  • DICOM RT support allows integration into existing radiation treatment plan workflows.
  • Provides segmentation results for on-screen review in multiplanar (Axial, Sagittal, Coronal) and 3D views.
  • Includes information related to ESTRO / RTOG guidelines for reference.

Limitations

  • No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.

Based on reviews from: youtube.com, instagram.com, auntminnie.com, healthcareaiops.com, healthairegister.com, corelinesoft.com, businesswire.com

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AVIEW RT ACS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Coreline Soft
AVIEW: RT ACS received FDA 510(k) clearance
Coreline Soft's AVIEW: RT ACS received FDA 510(k) clearance, a significant regulatory approval for its AI-based radiotherapy autocontouring system. This clearance allows the product to be marketed in the United States.
2022
Business Wire
Coreline Soft to Showcase AVIEW RT ACS at ECR 2024
Coreline Soft announced its participation in the European Congress of Radiology (ECR) 2024, where it demonstrated its AVIEW product line, including AVIEW RT ACS, an AI-based fully automated contouring solution. The company highlighted real-world applications and benefits for medical professionals.
2024-02
MT im Dialog
Coreline Soft Presents AVIEW RT ACS at ECR 2024
Coreline Soft showcased its AVIEW RT ACS, an AI-based fully automated contouring solution, at ECR 2024, emphasizing its role in improving workflow and diagnostic efficiency. The company also highlighted its expanding presence in the European market.
2024-03
Coreline Soft
Clinical Feasibility of MR-only Radiotherapy Workflow Using AVIEW RT-ACS
A study published in the Journal of Applied Clinical Medical Physics in November 2025 validated the clinical feasibility of an MR-only workflow in radiation therapy planning for cervical cancer patients, utilizing Coreline Soft's AVIEW RT-ACS system for contouring and dose calculation. The findings support the reliability of synthetic CT in such workflows.
2025-11
Coreline Soft
Abdominal multi-organ auto-segmentation using 3D-patch-based deep convolutional neural network
A study published in Nature/Scientific Reports in April 2020 evaluated the efficiency and accuracy of an auto-segmentation framework using a 3D-patch-based convolutional neural network for segmenting abdominal organs in radiotherapy. The concept of this study has been incorporated into AVIEW RT-ACS.
2020-04
Frontiers in Oncology (via NIH.gov)
Prediction of breast cancer-related lymphedema after radiotherapy using clinical and dosimetric parameters: a single-center retrospective study
A study published in Frontiers in Oncology in October 2022 utilized AVIEW RT ACS for auto-contouring in a retrospective study predicting breast cancer-related lymphedema after radiotherapy. The study aimed to generate a model for prediction of lymphedema risk using dosimetric parameters and clinical data.
2022-10

Videos

Product demos, reviews, and walkthroughs for AVIEW RT ACS.

Loading videos...

View all on YouTube

Frequently Asked Questions

AVIEW RT ACS is designed to automatically segment organs using deep learning AI technology, and its segmentation results can be referenced during radiation therapy planning. While the product documentation highlights its use of AI for automated contouring, specific details on how AVIEW RT ACS addresses AI bias and ensures generalizability across diverse patient populations are not explicitly provided. Generally, regulatory documents for AI systems may contain evidence of bias mitigation and strategies to limit dataset drift.
AVIEW RT ACS has received several global regulatory approvals and certifications. It is FDA cleared in the United States, has CE MDR for the European Union, and PMDA approval in Japan, along with MFDS in Korea.
AVIEW RT ACS supports AI auto-contouring of organs on CT for radiation therapy planning and research environments. It integrates into existing workflows by automatically segmenting normal organs and target structures, providing results that can be referenced during the radiation therapy planning process. The system supports DICOM RT, which helps it integrate into current radiation treatment plan workflows. After a CT scan, data is transferred to RT ACS, which then automatically segments organs and transmits the segmented data to the treatment planning system (TPS).
AVIEW RT ACS automates organ segmentation for radiation therapy planning, aiming to reduce preparation time. While it offers automated contouring for various body regions like the head, neck, breast, abdomen, and pelvis, the product information does not explicitly detail limitations concerning complex oncology cases or specific cancer types. However, a little final correction is required to complete contouring.
Yes, there are several other AI auto-contouring platforms for radiotherapy available. Some examples include AutoSeg, Radformation AutoContour, Limbus Contour, Siemens AI-Rad Companion Organs RT, RayStation DLS, MVision Contour+, MIM ProtégéAI+, TheraPanacea ART-Plan, Mirada DLCExpert, Carina INTContour, Oncosoft OncoStudio, and SegmentaR.
The pricing model for AVIEW RT ACS is not publicly available. Pricing information is typically indicative only and may vary by country, with additional charges for installation or activation options, and generally excludes delivery charges and customs duties. To obtain a quote or learn about the pricing structure, it is necessary to contact the supplier directly.

Related Tools

SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
Paid
CerviCARE AI
NTL Healthcare
OB/GYN AI
CerviCARE AI is an AI-powered cervical cancer screening system that analyzes smartphone images of the cervix to predict findings, aiming for early detection.
Lumonus AI
Lumonus
Clinical Decision Support & Reference
Lumonus AI is an AI-powered software that assists healthcare providers with prescriptions, dosing, and treatment for cancer patients, with a module (Sigma) that suggests treatment protocols based on prior plans for similar patients.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.
AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.
Surgical Reality Viewer
Surgical Reality
Oncology AI
Surgical Reality offers CE- and FDA-certified AI-powered 3D medical imaging and surgical planning software that transforms CT scans into patient-specific 3D models for thoracic surgery, enhancing precision in complex lung procedures.

See all Oncology AI tools →

More from Coreline Soft

A View LCS
Coreline Soft
Cardiology AI
AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.
AVIEW
Coreline Soft Co.
Cardiology AI
Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
Subscription; one-off payment
AVIEW CAC
Coreline Soft
Cardiology AI
AI-powered software for automated coronary artery calcium analysis from CT scans, providing quantitative results and risk assessment to aid in early detection and management of coronary artery disease.
Subscription or one-off payment
AVIEW LCS
Coreline Soft
Cardiology AI
Coreline Soft's AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules. The AVIEW LCS Plus platform provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, enhancing diagnostic accuracy and streamlining radiology workflows.
Subscription or one-off payment

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.